On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge

Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · see citing works

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67394-1 · Cited by 6,848 · see citing works

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489 · see citing works

Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis

Lorenz, M. W., Markus, H. S., Bots, M. L., Rosvall, M., & Sitzer, M. (2007) · Circulation · doi:10.1161/circulationaha.106.628875 · Cited by 2,977 · see citing works

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061894 · Cited by 2,887 · see citing works

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · see citing works

Relation Between Baseline and On-Treatment Lipid Parameters and First Acute Major Coronary Events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

Gotto, A. M., Whitney, E. J., Stein, E. A., Shapiro, D. R., Clearfield, M. B., Weis, S. E., Jou, J. Y., Langendörfer, A., Beere, P. A., Watson, D. J., et al. (2000) · Circulation · doi:10.1161/01.cir.101.5.477 · Cited by 562 · see citing works

Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment

Kastelein, J. J. P., van der Steeg, W. A., Holme, I., Gaffney, M., Cater, N. B., Barter, P., Deedwania, P., Olsson, A. G., Boekholdt, S. M., Demicco, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.713438 · Cited by 478 · see citing works

Effects of Intense Low-Density Lipoprotein Cholesterol Reduction in Patients With Stroke or Transient Ischemic Attack

Amarenco, P., Goldstein, L. B., Szarek, M. J., Sillesen, H. H., Rudolph, A. E., Callahan, A. S., III, Hennerici, M. G., Simunovic, L., Zivin, J. A., & Welch, K. M. A. (2007) · Stroke · doi:10.1161/strokeaha.107.493106 · Cited by 342 · see citing works

Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups

Tirschwell, D., Smith, N. L., Heckbert, S. R., Lemaître, R. N., Longstreth, W. T., Jr., & Psaty, B. M. (2004) · Neurology · doi:10.1212/01.wnl.0000144282.42222.da · Cited by 336 · see citing works

High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly: The Northern Manhattan Stroke Study

Sacco, R. L., Benson, R. T., Kargman, D. E., Boden-Albala, B., Tuck, C., Lin, I.-F., Cheng, J. F., Paik, M. C., Shea, S., & Berglund, L. (2001) · JAMA · doi:10.1001/jama.285.21.2729 · Cited by 311 · see citing works

Relationship Between Lipid Levels and Clinical Outcomes in the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Trial

Simes, R. J., Marschner, I. C., Hunt, D. U., Colquhoun, D., SULLIVAN, D. R., Stewart, R., Hague, W. E., KEECH, A. C., Thompson, P., White, H. D., et al. (2002) · Circulation · doi:10.1161/hc1002.105136 · Cited by 250 · see citing works

High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: A systematic review

Amarenco, P., Labreuche, J., & Touboul, P. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.07.033 · Cited by 232 · see citing works

Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?

Waters, D. D., Guyton, J. R., Herrington, D. M., McGowan, M. P., WENGER, N. K., & Shear, C. L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.031 · Cited by 200 · see citing works

Role of the Apolipoprotein B–Apolipoprotein A-I Ratio in Cardiovascular Risk Assessment: A Case–Control Analysis in EPIC-Norfolk

van der Steeg, W. A., Boekholdt, S. M., Stein, E. A., El-Harchaoui, K., Stroes, E. S. G., Sandhu, M. S., Wareham, N. J., Jukema, J. W., Luben, R., Zwinderman, A. H., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-9-200705010-00007 · Cited by 165 · see citing works

Safety and Efficacy of Atorvastatin-Induced Very Low-Density Lipoprotein Cholesterol Levels in Patients With Coronary Heart Disease (a Post Hoc Analysis of the Treating to New Targets [TNT] Study)††Conflicts of interest: Dr. LaRosa has served as a consultant to Pfizer, Inc., New York, New York; Merck Whitehouse Station, New Jersey; Bristol-Myers Squibb, New York, New York; and AstraZeneca, Wilmington, Delaware; and has received lecture fees from Pfizer. Dr. Grundy has consulted with Abbott, Chicago, Illinois; GlaxoSmithKline, Durham, North Carolina, Pfizer, AstraZeneca, and Sanofi-Aventis, Bridgewater, New Jersey; received lecture fees from Merck Schering Plough, Kenilworth, New Jersey; Kos, Edison, New Jersey, Pfizer, GlaxoSmithKline, Lilly, and Bristol-Myers Squibb; and received research support from Abbott and GlaxoSmithKline. Dr. Kastelein has received consulting fees, lecture fees, and grant support from Pfizer, Merck Schering Plough, Bristol-Myers Squibb, and Sankyo, Munich, Germany; Dr. Kostis has served as a consultant to Pfizer, Schering Plough, Berlex, Montville, New Jersey; Taisho, Tokyo, Japan; Forest Laboratories, New York, New York; and Sankyo; received lecture fees from Pfizer, Merck, Bristol-Myers Squibb, AstraZeneca, Sanofi Aventis, and Otsuka, Rockville, Maryland; and received grant support from Pfizer and Schering Plough. Dr. Greten has received consulting and lecturing fees from Pfizer, Merck, Schering Plough, and Kowa Company, Nagoya, Japan.

LaRosa, J. C., Grundy, S. M., Kastelein, J. J. P., Kostis, J. B., & Greten, H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.03.102 · Cited by 148 · see citing works

Childhood Levels of Serum Apolipoproteins B and A-I Predict Carotid Intima-Media Thickness and Brachial Endothelial Function in Adulthood

Juonala, M., Viikari, J. S. A., Kähönen, M. A. P., Solakivi, T., Helenius, H. Y. M., Jula, A., Marniemi, J., Taittonen, L. M., Laitinen, T. P., Nikkari, T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.054 · Cited by 146 · see citing works

The Friedewald Formula Underestimates LDL Cholesterol at low Concentrations

Scharnagl, H., Nauck, M. A., Wieland, H., & März, W. (2001) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2001.068 · Cited by 140 · see citing works

Stroke mortality and the apoB/apoA‐I ratio: results of the AMORIS prospective study

Walldius, G., AASTVEIT, A. H., & Jungner, I. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01610.x · Cited by 122 · see citing works

International Federation of Clinical Chemistry Standardization Project for Measurements of Apolipoproteins A-I and B. II. Evaluation and Selection of Candidate Reference Materials

Albers, J. J., Marcovina, S. M., & Kennedy, H. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.5.658 · Cited by 103 · see citing works

Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS)

Holme, I., AASTVEIT, A. H., Hammar, N., Jungner, I., & Walldius, G. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02016.x · Cited by 100 · see citing works

Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial

Amarenco, P., Goldstein, L. B., Callahan, A. S., III, Sillesen, H. H., Hennerici, M. G., O’Neill, B. J., Rudolph, A. E., Simunovic, L., Zivin, J. A., & Welch, K. M. A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.008 · Cited by 97 · see citing works

Effects of High-Dose Atorvastatin on Cerebrovascular Events in Patients With Stable Coronary Disease in the TNT (Treating to New Targets) Study

Waters, D. D., LaRosa, J. C., Barter, P. J., Fruchart, J., Gotto, A. M., Carter, R., Breazna, A., Kastelein, J. J. P., & Grundy, S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.041 · Cited by 75 · see citing works

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS)

Charlton-Menys, V., Betteridge, D. J., Colhoun, H. M., Fuller, J., France, M. W., Hitman, G. A., Livingstone, S. J., Neil, H. A. W., Newman, C. B., Szarek, M. J., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1176-8 · Cited by 41 · see citing works

Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease

Ricotta, J. J., AbuRahma, A. F., Ascher, E., Eskandari, M. K., Faries, P. L., & Lal, B. K. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.07.031 · Cited by 611 · see citing works

The Society for Vascular Surgery implementation document for management of extracranial cerebrovascular disease

AbuRahma, A. F., Avgerinos, E. D., Chang, R. W., Darling, R. C., Duncan, A. A., Forbes, T. L., Malas, M. B., Perler, B. A., Powell, R. J., Rockman, C. R., et al. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.04.074 · Cited by 198 · see citing works

The apoB/apoA-I Ratio is a Strong Predictor of Cardiovascular Risk

Walldius, G. (2012) · InTech eBooks · doi:10.5772/47869 · Cited by 36 · see citing works

N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events

Hoshi, R. A., Plavša, B., Liu, Y., Trbojević‐Akmačić, I., Glynn, R. J., Ridker, P. M., Cummings, R. D., Gudelj, I., Lauc, G., Demler, O., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323623 · Cited by 36 · see citing works

Avocado Consumption and Cardiometabolic Health: A Systematic Review and Meta-Analysis

James‐Martin, G., Brooker, P. G., Hendrie, G. A., & Stonehouse, W. (2022) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2022.12.008 · Cited by 25 · see citing works

Eucaloric diets enriched in palm olein, cocoa butter, and soybean oil did not differentially affect liver fat concentration in healthy participants: a 16-week randomized controlled trial.

Stonehouse, W., Sergi, D., Benassi-Evans, B., James-Martin, G., Johnson, N., Thompson, C. H., & Abeywardena, M. (2021) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa347 · Cited by 16 · see citing works

The association between lipid levels and leukocyte count: A cross-sectional and longitudinal analysis of three large cohorts

Sawant, S., Tucker, B., Senanayake, P., Waters, D. D., Patel, S., Rye, K., Ong, K. L., & Cochran, B. J. (2021) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2021.100024 · Cited by 12 · see citing works

High apoB/apoA-1 ratio is a strong risk predictor of major adverse cardio- and cerebrovascular events part 1: a review basis for updating guidelines

Walldius, G. (2025) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2025.2543537 · Cited by 4 · see citing works

Interventions in Carotid Artery Surgery

Banks, C. A., & Pearce, B. J. (2023) · Surgical Clinics of North America · doi:10.1016/j.suc.2023.05.003 · Cited by 1 · see citing works

Optimizing care for patients with symptomatic carotid disease

Kolkert, J. L. (2017) · University of Groningen research database (University of Groningen / Centre for Information Technology)

Epidemiology

Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678.ch5

Statin effects on immunoglobulin-G glycomic architecture and the link to cardiovascular diseasePreprint

Yazdani, A., Hoshi, R. A., Ammar, M., Li, C., Cummings, R. D., Akmačić-Trbojević, I., Cindrić, A., Šimunić-Briški, N., Gudelj, I., Glynn, R. J., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6112380/v1

Effects of High-Dose Atorvastatin on Cerebrovascular Events in Patients With Stable Coronary Disease in the TNT (Treating to New Targets) Study

Waters, D. D., LaRosa, J. C., Barter, P. J., Fruchart, J., Gotto, A. M., Carter, R., Breazna, A., Kastelein, J. J. P., & Grundy, S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.041 · Cited by 75 · see citing works

Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins: A Meta-analysis

Boekholdt, S. M., Arsenault, B. J., Mora, S., Pedersen, T. R., LaRosa, J. C., Nestel, P. J., Simes, R. J., Durrington, P., Hitman, G. A., Welch, K. M. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.366 · Cited by 795 · see citing works

TNT Trial

LaRosa, J. C., Grundy, S. M., & Waters, D. D. (2008) · Wiley Encyclopedia of Clinical Trials · doi:10.1002/9780471462422.eoct424

Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment

Kastelein, J. J. P., van der Steeg, W. A., Holme, I., Gaffney, M., Cater, N. B., Barter, P., Deedwania, P., Olsson, A. G., Boekholdt, S. M., Demicco, D. A., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.713438 · Cited by 478 · see citing works

Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis

Boekholdt, S. M., Arsenault, B. J., Hovingh, G. K., Mora, S., Pedersen, T. R., LaRosa, J. C., Welch, K. M. A., Amarenco, P., DeMicco, D. A., Tonkin, A. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002670 · Cited by 196 · see citing works